Are We Nearly There Yet? Starts and Stops on the Road to Use of Polygenic Scores
Overview
Overview
Journal
J Community Genet
Publisher
Springer
Specialty
Health Services
Date
2023 Sep 27
PMID
37759103
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Riddle L, Joseph G, Caruncho M, Koenig B, James J
. The role of polygenic risk scores in breast cancer risk perception and decision-making. J Community Genet. 2023; 14(5):489-501.
PMC: 10576692.
DOI: 10.1007/s12687-023-00655-x.
View
2.
Koch S, Schmidtke J, Krawczak M, Caliebe A
. Clinical utility of polygenic risk scores: a critical 2023 appraisal. J Community Genet. 2023; 14(5):471-487.
PMC: 10576695.
DOI: 10.1007/s12687-023-00645-z.
View
3.
Mason A, Obi I, Ayodele O, Lambert S, Fahle S
. What makes a good life: using theatrical performance to enhance communication about polygenic risk scores research in patient and public involvement. J Community Genet. 2023; 14(5):453-458.
PMC: 10576689.
DOI: 10.1007/s12687-023-00635-1.
View
4.
Pashayan N, Easton D, Michailidou K
. Polygenic risk scores in cancer screening: a glass half full or half empty?. Lancet Oncol. 2023; 24(6):579-581.
DOI: 10.1016/S1470-2045(23)00217-6.
View
5.
Johnston J, Matthews L
. Polygenic embryo testing: understated ethics, unclear utility. Nat Med. 2022; 28(3):446-448.
PMC: 9208380.
DOI: 10.1038/s41591-022-01743-0.
View